Skip to main content
Premium Trial:

Request an Annual Quote

Eagle Genomics Selected to Provide Tech Support for Commercial Ensembl Users

Premium

This week, Eagle Genomics said that it will partner with the European Bioinformatics Institute and the Wellcome Trust Sanger Institute to provide technical support for commercial developers and users of the Ensembl platform "who will benefit from an increased range and quality of support options."

The company said that both EBI and the Sanger Institute, who jointly run the database, have agreed to give Eagle access to the "know-how" of Ensembl project members with the goal of providing "commercial-grade support" in areas like user training and the development of plug-ins and modifications.

Paul Flicek, who leads the Ensembl project team at EBI, said the collaboration "extends the reach of Ensembl to those users that require service-level agreements, while benefiting the project through the integration of new features into our open-source platform.”

Under the terms of the agreement, the "collaboration does not provide any privileged access to the content of the Ensembl database … Eagle Genomics retains exactly the same access rights as any other user," the company said.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.